Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Itsuro Endo

9PUBLICATIONS
29CO-AUTHORS
Behavioural epidemiologyTe ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)Metabolic medicineMedical biochemistry - proteins and peptides (incl. medical proteomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|May 27, 2026
Liver Fibrosis Estimated Using Noninvasive Blood Biochemical Indices Is Correlated with Visit-to-Visit Glycated Hemoglobin A1c Variability in Individuals with Type 2 Diabetes.

|Jul 29, 2025
Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice.

Tomoyo Hara, Hiroki Yamagami, Ryoko Uemoto

|Jul 12, 2025
Mean Corpuscular Volume Is Correlated with Liver Fibrosis Defined by Noninvasive Blood Biochemical Indices in Individuals with Metabolic Disorders Aged 60 Years or Older.

Yousuke Kaneko, Yutaka Kawano, Saki Kawata

|Jan 10, 2025
Association Between Dynapenia/Sarcopenia, Extrapyramidal Symptoms, Negative Symptoms, Body Composition, and Nutritional Status in Patients with Chronic Schizophrenia.

Reiko Kamoi, Yoshihiro Mifune, Krishan Soriano

|Aug 29, 2024
Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes.

Tomoyo Hara, Takeshi Watanabe, Hiroki Yamagami

|Jun 19, 2024
Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1.

Mai Kanai, Byambasuren Ganbaatar, Itsuro Endo

Pageof 2

Frequent Collaborators

5 joint publications

Ken-Ichi Aihara

4 joint publications

Toshiki Otoda

4 joint publications

Shingen Nakamura

4 joint publications

Takeshi Harada

3 joint publications

Taiki Hori

3 joint publications

Munehide Matsuhisa

3 joint publications

Tomoyo Hara

2 joint publications

Yutaka Kawano

2 joint publications

Hiroshi Sakaue

2 joint publications

Masahiro Hiasa

Frequent Collaborators

5 joint publications

Ken-Ichi Aihara

4 joint publications

Toshiki Otoda

4 joint publications

Shingen Nakamura

4 joint publications

Takeshi Harada